Steven D. Hatch
Eli Lilly (United States)(US)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, Chemical Synthesis and Analysis, HIV Research and Treatment, Click Chemistry and Applications, Hepatitis C virus research
Most-Cited Works
- → Viracept (Nelfinavir Mesylate, AG1343): A Potent, Orally Bioavailable Inhibitor of HIV-1 Protease(1997)619 cited
- → Potent Human Immunodeficiency Virus Type 1 Protease Inhibitors That Utilize Noncoded d-Amino Acids as P2/P3 Ligands(1996)41 cited
- → Isophthalic acid derivatives: amino acid surrogates for the inhibition of HIV-1 protease(1995)17 cited
- → A systematic study of P1–P3 spanning sidechains for the inhibition of HIV-1 protease(1995)16 cited
- → Abstract B235: Characterization of LY2228820 dimesylate, a potent and selective inhibitor of p38 MAPK with antitumor activity.(2011)